Home Tools
Log in
Cart

Search Result

Search Results for " mll "

20

Compounds

Cat No. Product Name Synonyms Targets
T9399 Menin-MLL inhibitor 20 Epigenetic Reader Domain , Histone Methyltransferase
Menin-MLL inhibitor 20 is an irreversible inhibitor of menin-MLL interaction with antitumor activities.
T2649 Menin-MLL inhibitor MI-2 Menin-MLL Inhibitor,MI2,MI-2,Menin-MLL inhibitor 2,MI 2 Apoptosis , Epigenetic Reader Domain , Histone Methyltransferase
Menin-MLL inhibitor MI-2 (MI2) is a potent menin-MLL interaction inhibitor with IC50 of 446 nM.
T2643 MI-3 Menin-MLL Inhibitor,Menin-MLL inhibitor 3,MI 3 Apoptosis , Epigenetic Reader Domain , Histone Methyltransferase
MI-3 (Menin-MLL Inhibitor) (Menin-MLL Inhibitor) is an effective inhibitor of Menin-MLL interaction (IC50: 648 nM).
T69629 M‑89 MLL inhibitor
M‑89 is a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein−Protein Interaction (Kd = 1.4 nM; IC50 = 25nM). M-89 binds to menin with a Kd value of 1.4 nM and effectively engages cellular men...
T12002 Menin-MLL inhibitor 4 Others
Menin-MLL inhibitor 4 has antitumor activity.Menin-MLL inhibitor 4 is an inhibitor of Menin- MLL (mixed-lineage leukemia protein) interaction .
T79737 Menin-MLL inhibitor 29 Epigenetic Reader Domain
Menin-MLL Inhibitor 29 (Compound C1) is a Menin-MLL protein-protein interaction (PPI) inhibitor that demonstrates high affinity to Menin with a dissociation constant (K D) of 138 nM and impedes Menin's interaction with M...
T78151 Bleximenib oxalate Menin-MLL inhibitor 24 oxalate Epigenetic Reader Domain
Menin-MLL Inhibitor 24 (compound A) oxalate, a menin-mixed-lineage leukemia 1 (menin-MLL) inhibitor, is utilized in cancer research [1].
T72360 Menin-MLL inhibitor 26
Menin-MLL inhibitor 26 is a Menin-MLL inhibitor. Menin-MLL inhibitor 26 also is an active reference. Menin-MLL inhibitor 26 can inhibits cell growth. Menin-MLL inhibitor 26 can be used for the research of leukemia .
T79117 Menin-MLL inhibitor 27 Epigenetic Reader Domain
Menin-MLL inhibitor 27 effectively inhibits the interaction between Menin and MLL, serving as a potential tool in cancer research, particularly for acute myeloid leukemia (AML) [1].
T72135 (1s,4s)-Menin-MLL inhibitor-23
(1s,4s)-Menin-MLL Inhibitor-23, an enantiomer of Menin-MLL Inhibitor-23 (Example 99A), functions as an inhibitor of the menin-MLL interaction [1].
T3082 SGC0946 Histone Methyltransferase
SGC0946 is a highly effective and specific DOT1L methyltransferase inhibitor (IC50: 0.3 nM); selectively kill mixed lineage leukemia cells.
T8838 CCI-007 Apoptosis , Histone Methyltransferase
CCI 007 is a selective inhibitor of MLL-r, CALM-AF10 and SET-NUP214 leukemia with IC50 of 3.5 uM against MLL-r leukemia cell line PER-485
T12943 SNDX-5613 Epigenetic Reader Domain , Histone Methyltransferase
SNDX-5613 is a potent and specific inhibitor of Menin-MLL(Ki of 0.149 nM and a cell based IC50 of 10-20 nM). SNDX-5613 can be used for the research of MLL-rearranged (MLL-r) acute leukemias.
T13336 VTP50469 Apoptosis , Epigenetic Reader Domain , Histone Methyltransferase
VTP50469 is a highly selective and orally active inhibitor of Menin-MLL interaction( Ki: 104 pM) and has potently anti-leukemia activity.
T6916 OICR-9429 OICR 9429 Histone Methyltransferase , JAK
OICR-9429 is a potent antagonist of the interaction that WDR5 effect with peptide regions of MLL and Histone 3. It reduces the viability of acute myeloid leukemia cells in vitro.
T28036 MI-2-2 MI22,MI 2 2 Histone Methyltransferase
MI-2-2 is an inhibitor of bivalent protein-protein interaction between menin and MLL with an IC50 of 46 nM. MI-2-2 binds to menin with Kd of 22 nM.
T69628 Iptacopan hydrochloride hydrate
Iptacopan hydrochloride hydrate is a highly potent and highly selective factor B inhibitor.
T69581 NVS MLLT-1
NVS-MLLT-1 is a selective inhibitor of YEATS domain of MLLT1 and MLLT3.
T12886 SGC-iMLLT Histone Methyltransferase
SGC-iMLLT is a potent and selective MLLT1/3-histone interactions inhibitor(IC50 = 0.26 μM),and is a first-in-class chemical probe displaying cellular target engagement of MLLT1(Kd = 0.129 μM) and MLLT3(Kd = 0.077 μM).
TQ0069 MI-503 Epigenetic Reader Domain , Histone Methyltransferase
MI-503 is a highly effective and orally bioavailable inhibitor of the menin-mLL interaction.

Compounds

Menin-MLL inhibitor 20
T9399
Synonym:
Target: Epigenetic Reader Domain, Histone Methyltransferase
Menin-MLL inhibitor MI-2
T2649
Synonym: Menin-MLL Inhibitor,MI2,MI-2,Menin-MLL inhibitor 2,MI 2
Target: Apoptosis, Epigenetic Reader Domain, Histone Methyltransferase
MI-3
T2643
Synonym: Menin-MLL Inhibitor,Menin-MLL inhibitor 3,MI 3
Target: Apoptosis, Epigenetic Reader Domain, Histone Methyltransferase
M‑89 MLL inhibitor
T69629
Synonym:
Target:
Menin-MLL inhibitor 4
T12002
Synonym:
Target: Others
Menin-MLL inhibitor 29
T79737
Synonym:
Target: Epigenetic Reader Domain
Bleximenib oxalate
T78151
Synonym: Menin-MLL inhibitor 24 oxalate
Target: Epigenetic Reader Domain
Menin-MLL inhibitor 26
T72360
Synonym:
Target:
Menin-MLL inhibitor 27
T79117
Synonym:
Target: Epigenetic Reader Domain
(1s,4s)-Menin-MLL inhibitor-23
T72135
Synonym:
Target:
SGC0946
T3082
Synonym:
Target: Histone Methyltransferase
CCI-007
T8838
Synonym:
Target: Apoptosis, Histone Methyltransferase
SNDX-5613
T12943
Synonym:
Target: Epigenetic Reader Domain, Histone Methyltransferase
VTP50469
T13336
Synonym:
Target: Apoptosis, Epigenetic Reader Domain, Histone Methyltransferase
OICR-9429
T6916
Synonym: OICR 9429
Target: Histone Methyltransferase, JAK
MI-2-2
T28036
Synonym: MI22,MI 2 2
Target: Histone Methyltransferase
Iptacopan hydrochloride hydrate
T69628
Synonym:
Target:
NVS MLLT-1
T69581
Synonym:
Target:
SGC-iMLLT
T12886
Synonym:
Target: Histone Methyltransferase
MI-503
TQ0069
Synonym:
Target: Epigenetic Reader Domain, Histone Methyltransferase
1 2 3
TargetMol